Artykuły w czasopismach na temat „Nanoparticulate System”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Nanoparticulate System”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Chen, Hongbing, and Fengling Jia. "Global Solution and Stability of a Haptotaxis Mathematical Model for Complex MAP." Mathematics 12, no. 7 (2024): 1116. http://dx.doi.org/10.3390/math12071116.
Pełny tekst źródłaNishioka, Yukiko, and Hiroyuki Yoshino. "Lymphatic targeting with nanoparticulate system." Advanced Drug Delivery Reviews 47, no. 1 (2001): 55–64. http://dx.doi.org/10.1016/s0169-409x(00)00121-6.
Pełny tekst źródłaS, Venkateswara Rao, Jagadeeswari N, and Padmalatha K. "Aquasomes: A Nanoparticulate Drug Carrier System." American Journal of PharmTech Research 8, no. 6 (2018): 28–37. http://dx.doi.org/10.46624/ajptr.2018.v8.i6.004.
Pełny tekst źródłaAbdelrahim, Adel S., Pavla Simerska, and Istvan Toth. "Liposaccharide-based nanoparticulate drug delivery system." Tetrahedron 68, no. 25 (2012): 4967–75. http://dx.doi.org/10.1016/j.tet.2012.04.064.
Pełny tekst źródłaSindhuja Devaraj and Ganesh GNK. "Nanoparticulate targeted drug delivery systems - A Review." International Journal of Research in Pharmaceutical Sciences 11, no. 2 (2020): 2505–18. http://dx.doi.org/10.26452/ijrps.v11i2.2246.
Pełny tekst źródłaAshara, Kalpesh C., Jalpa S. Paun, M. M. Soniwala, J. R. Chavada, and J. K. Badjatiya. "NANOPARTICULATE DRUG DELIVERY SYSTEM: A NOVEL APPROACH." International Journal of Drug Regulatory Affairs 1, no. 2 (2018): 39–48. http://dx.doi.org/10.22270/ijdra.v1i2.109.
Pełny tekst źródłaJaswinder, Singh *. "LIPID NANOPARTICULATE DRUG DELIVERY SYSTEMS." Journal of Pharma Research 8, no. 8 (2019): 557–63. https://doi.org/10.5281/zenodo.3374087.
Pełny tekst źródłaPalanisamy, Sathyadevi, and Yun-Ming Wang. "Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer." Dalton Transactions 48, no. 26 (2019): 9490–515. http://dx.doi.org/10.1039/c9dt00459a.
Pełny tekst źródłaAlbarqi, Hassan A., Anuj Garg, Mohammad Zaki Ahmad, Abdulsalam A. Alqahtani, Ismail A. Walbi, and Javed Ahmad. "Recent Progress in Chitosan-Based Nanomedicine for Its Ocular Application in Glaucoma." Pharmaceutics 15, no. 2 (2023): 681. http://dx.doi.org/10.3390/pharmaceutics15020681.
Pełny tekst źródłaMd., Shadab, Shadabul Haque, Ravi Sheshala, Lim Wei Meng, Venkata Srikanth Meka, and Javed Ali. "Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System." Current Pharmaceutical Design 23, no. 3 (2017): 440–53. http://dx.doi.org/10.2174/1381612822666161026163201.
Pełny tekst źródłaBera, Raj Kumar, Tripti Pal, Nilanjana Ghosh, et al. "Nanomaterials Drug Delivery System in Herbal Formulation For Antidiabetic Activity: A Review." International Journal of Membrane Science and Technology 10, no. 5 (2023): 955–73. http://dx.doi.org/10.15379/ijmst.v10i5.3635.
Pełny tekst źródłaHaider, Nafis, Sana Fatima, Murtada Taha, et al. "Nanomedicines in Diagnosis and Treatment of Cancer: An Update." Current Pharmaceutical Design 26, no. 11 (2020): 1216–31. http://dx.doi.org/10.2174/1381612826666200318170716.
Pełny tekst źródłaGidwani, SK, and PS Singnurkar. "Evaluation of hydrophobic nanoparticulate delivery system for insulin." Indian Journal of Pharmaceutical Sciences 70, no. 6 (2008): 721. http://dx.doi.org/10.4103/0250-474x.49091.
Pełny tekst źródłaKumar, D., and PK Sharma. "Nanoparticulate system for cancer therapy: An updated review." International Journal of Nanomaterials, Nanotechnology and Nanomedicine 4, no. 2 (2018): 022–34. http://dx.doi.org/10.17352/2455-3492.000027.
Pełny tekst źródłaKim, In-Sook, and Sung-Ho Kim. "Development of a polymeric nanoparticulate drug delivery system." International Journal of Pharmaceutics 245, no. 1-2 (2002): 67–73. http://dx.doi.org/10.1016/s0378-5173(02)00336-8.
Pełny tekst źródłaProkop, Ales, Celia A. Holland, Evgenii Kozlov, Billy Moore, and Robert D. Tanner. "Water-based nanoparticulate polymeric system for protein delivery." Biotechnology and Bioengineering 75, no. 2 (2001): 228–32. http://dx.doi.org/10.1002/bit.10025.
Pełny tekst źródłaDharmendra, Kumar. "Nanoparticulate system for cancer therapy: An updated review." International Journal of Nanomaterials, Nanotechnology and Nanomedicine 4, no. 2 (2018): 022–34. https://doi.org/10.17352/2455-3492.000027.
Pełny tekst źródłaSenthil Kumar C, Moorthi C, Sundararajan N, Sivasakthi R, and Mohan S. "Formulation and Evaluation of Duo Flavono Loaded Anionic Polymeric Nanoparticulate System." International Journal of Research in Pharmaceutical Sciences 12, no. 1 (2021): 553–61. http://dx.doi.org/10.26452/ijrps.v12i1.4117.
Pełny tekst źródłaHodnik, Nejc, Chinnaiah Jeyabharathi, Josef C. Meier, et al. "Effect of ordering of PtCu3nanoparticle structure on the activity and stability for the oxygen reduction reaction." Phys. Chem. Chem. Phys. 16, no. 27 (2014): 13610–15. http://dx.doi.org/10.1039/c4cp00585f.
Pełny tekst źródłaMahaling, Binapani, Dadi A. Srinivasarao, G. Raghu, Rajesh K. Kasam, G. Bhanuprakash Reddy, and Dhirendra S. Katti. "A non-invasive nanoparticle mediated delivery of triamcinolone acetonide ameliorates diabetic retinopathy in rats." Nanoscale 10, no. 35 (2018): 16485–98. http://dx.doi.org/10.1039/c8nr00058a.
Pełny tekst źródłaPaithankar, Mahesh, and Mangesh Bhalekar. "Quality by Design Enabled Development and Optimization of the Nanoparticulate System of Cabazitaxel." International Journal of Pharmaceutical Sciences and Drug Research 14, no. 01 (2022): 112–21. http://dx.doi.org/10.25004/ijpsdr.2022.140115.
Pełny tekst źródłada Silva, Raimundo Lopes, Jaqueline Rodrigues da Silva, Anivaldo Pereira Duarte Júnior, et al. "Adsorption of Vi Capsular Antigen of Salmonella Typhi in Chitosan–Poly (Methacrylic Acid) Nanoparticles." Polymers 11, no. 7 (2019): 1226. http://dx.doi.org/10.3390/polym11071226.
Pełny tekst źródłaCraparo, Emanuela Fabiola, Maria Luisa Bondì, Giovanna Pitarresi, and Gennara Cavallaro. "Nanoparticulate Systems for Drug Delivery and Targeting to the Central Nervous System." CNS Neuroscience & Therapeutics 17, no. 6 (2010): 670–77. http://dx.doi.org/10.1111/j.1755-5949.2010.00199.x.
Pełny tekst źródłaJain, NK, Suman Ramteke, and RB Uma Maheshwari. "Clarithromycin based oral sustained release nanoparticulate drug delivery system." Indian Journal of Pharmaceutical Sciences 68, no. 4 (2006): 479. http://dx.doi.org/10.4103/0250-474x.27822.
Pełny tekst źródłaSharma, Kritika, Kulyash Kumar, and Neeraj Mishra. "Nanoparticulate carrier system: a novel treatment approach for hyperlipidemia." Drug Delivery 23, no. 3 (2014): 684–99. http://dx.doi.org/10.3109/10717544.2014.920937.
Pełny tekst źródłaYamamoto, Hiromitsu, Hirofumi Takeuchi, and Yoshiaki Kawashima. "Design of Polymeric Nanoparticulate System for Mucosal Peptide Delivery." Drug Delivery System 15, no. 5 (2000): 415–20. http://dx.doi.org/10.2745/dds.15.415.
Pełny tekst źródłaAhmed, Ayaz, Hemant K.S. Yadav, Sureddi V. Lakshmi, Bala V.N. Namburi, and Hosakote G. Shivakumar. "Mucoadhesive Nanoparticulate System for Oral Drug Delivery: A Review." Current Drug Therapy 7, no. 1 (2012): 42–55. http://dx.doi.org/10.2174/157488512800389137.
Pełny tekst źródłaKos, Janko, Nataša Obermajer, Bojan Doljak, Petra Kocbek, and Julijana Kristl. "Inactivation of harmful tumour-associated proteolysis by nanoparticulate system." International Journal of Pharmaceutics 381, no. 2 (2009): 106–12. http://dx.doi.org/10.1016/j.ijpharm.2009.04.037.
Pełny tekst źródłaMu, L., and P. H. Seow. "Application of TPGS in polymeric nanoparticulate drug delivery system." Colloids and Surfaces B: Biointerfaces 47, no. 1 (2006): 90–97. http://dx.doi.org/10.1016/j.colsurfb.2005.08.016.
Pełny tekst źródłaTamba, B. I., V. Streinu, D. Iurea, M. Popa, J. F. Chailan, and C. Peptu. "PP275—Chitosan/polymer nanoparticulate controlled release system for ibuprofen." Clinical Therapeutics 35, no. 8 (2013): e104. http://dx.doi.org/10.1016/j.clinthera.2013.07.303.
Pełny tekst źródłavan Leeuwen, Herman P. "Steady-state DGT fluxes of nanoparticulate metal complexes." Environmental Chemistry 8, no. 5 (2011): 525. http://dx.doi.org/10.1071/en11022.
Pełny tekst źródłaSanjay K Gowda, Rupesh Kumar M, Syed Sagheer Ahmed, Rajesh Kowti, Abhishek K, and Ramesh B. "Importance of Nanoparticulate systems in emerging Biomedical research - An update." International Journal of Research in Pharmaceutical Sciences 11, SPL4 (2020): 2134–40. http://dx.doi.org/10.26452/ijrps.v11ispl4.4433.
Pełny tekst źródłaMosallaei, Navid, Amirhossein Malaekeh-Nikouei, Setayesh Sarraf Shirazi, Javad Behmadi, and Bizhan Malaekeh-Nikouei. "A comprehensive review on alpha-lipoic acid delivery by nanoparticles." BioImpacts 14 (February 26, 2024): 30136. http://dx.doi.org/10.34172/bi.2024.30136.
Pełny tekst źródłaShirsath, Nitin R., and Ajaygiri K. Goswami. "Nanocarriers Based Novel Drug Delivery as Effective Drug Delivery: A Review." Current Nanomaterials 4, no. 2 (2019): 71–83. http://dx.doi.org/10.2174/2405461504666190527101436.
Pełny tekst źródłaGadade, Dipak Dilip, and Sanjay Sudhakar Pekamwar. "Cyclodextrin Based Nanoparticles for Drug Delivery and Theranostics." Advanced Pharmaceutical Bulletin 10, no. 2 (2020): 166–83. http://dx.doi.org/10.34172/apb.2020.022.
Pełny tekst źródłaKIRAN, KULKARNI SACHIN LOKAPURE AMRUTA TIDAKE. "A BRIEF REVIEW ON ROLE OF NANOCARRIER AS ANTIHYPERTNESIVE AGENTS." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES o6, no. 03 (2019): 6973–87. https://doi.org/10.5281/zenodo.2619939.
Pełny tekst źródłaMathur, Prateek, Shruti Rawal, Bhoomika Patel, and Mayur M. Patel. "Oral Delivery of Anticancer Agents Using Nanoparticulate Drug Delivery System." Current Drug Metabolism 20, no. 14 (2020): 1132–40. http://dx.doi.org/10.2174/1389200220666191007154017.
Pełny tekst źródłaCarlesso, Gianluca, Eugene Kozlov, Ales Prokop, Derya Unutmaz, and Jeffrey M. Davidson. "Nanoparticulate System for Efficient Gene Transfer into Refractory Cell Targets†." Biomacromolecules 6, no. 3 (2005): 1185–92. http://dx.doi.org/10.1021/bm0492531.
Pełny tekst źródłaArias, José L., L. Harivardhan Reddy, and Patrick Couvreur. "Superior Preclinical Efficacy of Gemcitabine Developed As Chitosan Nanoparticulate System." Biomacromolecules 12, no. 1 (2011): 97–104. http://dx.doi.org/10.1021/bm101044h.
Pełny tekst źródłaMontero, M. I., M. Emura, F. Cebollada, J. M. González, E. M. González, and J. L. Vicent. "Coercivity analysis in the Cox/(SiO2)100−x nanoparticulate system." Journal of Magnetism and Magnetic Materials 203, no. 1-3 (1999): 205–7. http://dx.doi.org/10.1016/s0304-8853(99)00235-8.
Pełny tekst źródłaLi, Jiayu, Jian Yang, and Xiaobing Gu. "The distribution of absorptive power dissipation in irradiated nanoparticulate system." Journal of Quantitative Spectroscopy and Radiative Transfer 182 (October 2016): 102–11. http://dx.doi.org/10.1016/j.jqsrt.2016.05.017.
Pełny tekst źródłaArias, José L., L. Harivardhan Reddy, and Patrick Couvreur. "Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine." Journal of Drug Targeting 17, no. 8 (2009): 586–98. http://dx.doi.org/10.1080/10611860903105739.
Pełny tekst źródłaNagarwal, Ramesh C., Shri Kant, P. N. Singh, P. Maiti, and J. K. Pandit. "Polymeric nanoparticulate system: A potential approach for ocular drug delivery." Journal of Controlled Release 136, no. 1 (2009): 2–13. http://dx.doi.org/10.1016/j.jconrel.2008.12.018.
Pełny tekst źródłaDessai, Ashveta Anant, Mrunali Navin Kantak, Cleona Elizabeth Mary DCruz, Lalit Kumar, Prashant Jivaji Bhide, and Rupesh Kalidas Shirodkar. "Formulation and Characterization of Nanoparticulate Drug Carrier System for Lacidipine." ASSAY and Drug Development Technologies 21, no. 7 (2023): 309–24. http://dx.doi.org/10.1089/adt.2023.023.
Pełny tekst źródłaMr. Harshal Anil Mane, Mr Harshal Anil Mane, Miss Akshata Vishwanth Shinde, Mr Tejmal Premsing Rathod, et al. "Aquasomes: A Novel Nanoparticulate Drug Delivery System for Psoriasis Treatment." International Journal of Pharmaceutical Research and Applications 10, no. 3 (2025): 1922–28. https://doi.org/10.35629/4494-100319221928.
Pełny tekst źródłaKotla, Niranjan G., Orla Burke, Abhay Pandit, and Yury Rochev. "An Orally Administrated Hyaluronan Functionalized Polymeric Hybrid Nanoparticle System for Colon-Specific Drug Delivery." Nanomaterials 9, no. 9 (2019): 1246. http://dx.doi.org/10.3390/nano9091246.
Pełny tekst źródłaDembele, Kadiatou Therese, Gurpreet Singh Selopal, Riccardo Milan, et al. "Graphene below the percolation threshold in TiO2 for dye-sensitized solar cells." Journal of Materials Chemistry A 3, no. 6 (2015): 2580–88. http://dx.doi.org/10.1039/c4ta04395b.
Pełny tekst źródłaDe Souza Rebouças, Juliana, Irene Esparza, Marta Ferrer, María Luisa Sanz, Juan Manuel Irache, and Carlos Gamazo. "Nanoparticulate Adjuvants and Delivery Systems for Allergen Immunotherapy." Journal of Biomedicine and Biotechnology 2012 (2012): 1–13. http://dx.doi.org/10.1155/2012/474605.
Pełny tekst źródłaDeep, Aakash, Neeraj Rani, Ashok Kumar, Rimmy Nandal, Prabodh C. Sharma, and Arun K. Sharma. "Prospective of Natural Gum Nanoparticulate Against Cardiovascular Disorders." Current Chemical Biology 13, no. 3 (2019): 197–211. http://dx.doi.org/10.2174/2212796813666190328194825.
Pełny tekst źródłaFazil, Mohammad, Md Quamrul Hassan, Sanjula Baboota, and Javed Ali. "Biodegradable intranasal nanoparticulate drug delivery system of risedronate sodium for osteoporosis." Drug Delivery 23, no. 7 (2015): 2428–38. http://dx.doi.org/10.3109/10717544.2014.1002947.
Pełny tekst źródła